On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

PIGN

phosphatidylinositol glycan anchor biosynthesis class N

The PIGN gene encodes an enzyme crucial for the biosynthesis of glycophosphatidylinositol (GPI) anchors, which are essential for attaching various proteins to the cell surface. The PIGN gene provides instructions for making GPI ethanolamine phosphate transferase 1, an enzyme that plays a key role in creating glycophosphatidylinositol (GPI) anchors.

Chromosome 18q21.33 Autosomal recessive HGNC:8967 Tier C
PIGN 18q21.33 p arm q arm 18

PIGN is located on the long (q) arm of chromosome 18, at band 18q21.33. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 18 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The PIGN gene, also known as phosphatidylinositol glycan anchor biosynthesis class N, is involved in a fundamental cellular process: the synthesis of glycophosphatidylinositol (GPI) anchors. These anchors are complex molecules that enable many different proteins to attach to the outer surface of cell membranes. The accurate production and attachment of GPI anchors are essential for a wide range of cellular activities.

Inherited variants in the PIGN gene are associated with several rare genetic conditions that can affect multiple bodily systems.

What the gene does

The PIGN gene provides instructions for producing an enzyme called GPI ethanolamine phosphate transferase 1. This enzyme is a critical component in the multi-step pathway of glycophosphatidylinositol (GPI) anchor biosynthesis, which occurs within the endoplasmic reticulum, a cell structure involved in protein processing. The GPI anchor itself is composed of various smaller molecules.

Once a GPI anchor is fully assembled, it binds to specific proteins, known as GPI-anchored proteins. This attachment then facilitates the anchoring of these proteins to the outer leaflet of the cell membrane. GPI-anchored proteins are involved in a diverse array of cellular processes, including cell adhesion (how cells stick together), cell signalling (how cells communicate), and cellular immunity (protecting against foreign invaders). Their proper function relies on the correct synthesis and attachment of the GPI anchor.

Video: Genetics 101

Chromosome location

The PIGN gene is located on chromosome 18 at position 18q21.33. This specific genomic address helps to identify its precise location within the human genome. The PIGN gene codes for a protein that is 931 amino acids in length.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Variants within the PIGN gene can alter the function of the GPI ethanolamine phosphate transferase 1 enzyme, potentially disrupting the normal biosynthesis of GPI anchors. These genetic changes are typically inherited in an autosomal recessive pattern.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for PIGN.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1556G>A
single nucleotide variant
p.Trp519Ter Pathogenic/Likely pathogenic ★★☆☆ PIGN-related disorder
c.2125C>T
single nucleotide variant
p.Arg709Ter Pathogenic/Likely pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.2237_2238del
Deletion
p.Ile746fs Pathogenic/Likely pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.2329C>T
single nucleotide variant
p.Arg777Ter Pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.2399G>A
single nucleotide variant
p.Gly800Glu Pathogenic/Likely pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.465T>A
single nucleotide variant
p.Tyr155Ter Pathogenic/Likely pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.601_602insT
Insertion
p.Glu201fs Pathogenic/Likely pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.629T>G
single nucleotide variant
p.Leu210Ter Pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.718G>T
single nucleotide variant
p.Glu240Ter Pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1
c.817dup
Duplication
p.Ala273fs Pathogenic/Likely pathogenic ★★☆☆ Multiple congenital anomalies-hypotonia-seizures syndrome 1

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the PIGN gene are associated with several rare genetic conditions, including Fryns syndrome and multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). These conditions often present with a range of developmental and neurological symptoms, reflecting the broad importance of GPI-anchored proteins in cellular function.

No disease links recorded for this gene in our reference set.

Inheritance pattern

Conditions caused by pathogenic PIGN variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous PIGN carrier status across ancestry groups?

UK clinical status

The PIGN gene is assessed by the UK's National Health Service (NHS) Genomic Medicine Service. It is currently featured on several Green RAG status panels within NHS Genomic Medicine Service laboratories, indicating that there is strong evidence for its association with specific conditions. These panels include Clefting, Congenital disorders of glycosylation, DDG2P, Early onset or syndromic epilepsy, Foetal anomalies (R21), Intellectual disability, Likely inborn error of metabolism (R98), and Undiagnosed metabolic disorders.

Frequently asked questions

What is a GPI anchor?

A GPI anchor is a special molecule that helps attach certain proteins to the outer surface of cell membranes. These anchored proteins are crucial for various cellular activities, such as cell communication and immunity.

What is the function of the PIGN gene?

The PIGN gene provides instructions for making an enzyme called GPI ethanolamine phosphate transferase 1. This enzyme is essential for one of the steps in building the glycophosphatidylinositol (GPI) anchor.

How are PIGN gene variants inherited?

Variants in the PIGN gene are typically inherited in an autosomal recessive manner. This means an individual must inherit two copies of the altered gene (one from each parent) to develop a condition associated with PIGN.

References

  1. Adam MP, Bick S, Mirzaa GM. Fryns Syndrome. 1993. PMID: 20301632
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 4 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .